(1 - 22 from 22
)
VolitionRx : CSO Dr. Jake Micallef to Present Scientific ...
www.marketscreener.com
NAMUR, Belgium, July 8, PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX) today announced that its Chief Scientific Officer, Dr. Jake Micallef, will present an informational webcast on July 15 about the company's blood-based diagnostic tests for a broad range of cancers and other conditions ...
www.biospectrumasia.com › news › volitionrx-to-test-nuq-on-wales-c...VolitionRx to test NuQ on Wales Cancer Bank
www.biospectrumasia.com
Mr Jake Micallef, chief scientific officer, VolitionRx, said, "These larger studies follow successful completion of our own internal pilot studies.
www.medicaldevice-network.com › news › volitionrx-reports-positive...VolitionRx reports positive data for prostate cancer assay
www.medicaldevice-network.com
Volition chief scientific officer Jake Micallef said: “Based on this data, we believe that this test could assist clinicians in more accurate patient ...
www.proactiveinvestors.com › companies › news › volitionrx-hits-mil...VolitionRx Limited hits milestone in Nu.Q Capture blood ...
www.proactiveinvestors.com
Chief Scientific Officer Jake Micallef said the company has hit a breakthrough after nearly a decade in epigenetics, which studies the effects of ...
sorted by relevance / date